DK0608235T4 - Fremgangsmåde til diagnose af blodkoagulationssygdomme - Google Patents

Fremgangsmåde til diagnose af blodkoagulationssygdomme

Info

Publication number
DK0608235T4
DK0608235T4 DK92913443T DK92913443T DK0608235T4 DK 0608235 T4 DK0608235 T4 DK 0608235T4 DK 92913443 T DK92913443 T DK 92913443T DK 92913443 T DK92913443 T DK 92913443T DK 0608235 T4 DK0608235 T4 DK 0608235T4
Authority
DK
Denmark
Prior art keywords
diagnosis
conversion
sample
rate
procedure
Prior art date
Application number
DK92913443T
Other languages
English (en)
Other versions
DK0608235T3 (da
Inventor
A C Thrombosis And Coagulati T
Original Assignee
A C Thrombosis And Coagulati T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26661244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0608235(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9103332A external-priority patent/SE470274B/sv
Application filed by A C Thrombosis And Coagulati T filed Critical A C Thrombosis And Coagulati T
Application granted granted Critical
Publication of DK0608235T3 publication Critical patent/DK0608235T3/da
Publication of DK0608235T4 publication Critical patent/DK0608235T4/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK92913443T 1991-11-13 1992-05-13 Fremgangsmåde til diagnose af blodkoagulationssygdomme DK0608235T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9103332A SE470274B (sv) 1991-11-13 1991-11-13 Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
US81130391A 1991-12-20 1991-12-20
PCT/SE1992/000310 WO1993010261A1 (en) 1991-11-13 1992-05-13 Method for the diagnosis of blood coagulation disorders

Publications (2)

Publication Number Publication Date
DK0608235T3 DK0608235T3 (da) 1996-02-12
DK0608235T4 true DK0608235T4 (da) 2005-05-30

Family

ID=26661244

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92913443T DK0608235T4 (da) 1991-11-13 1992-05-13 Fremgangsmåde til diagnose af blodkoagulationssygdomme

Country Status (10)

Country Link
EP (1) EP0608235B2 (da)
JP (1) JP2562000B2 (da)
AT (1) ATE132909T1 (da)
CA (1) CA2119761C (da)
DE (2) DE69207607T3 (da)
DK (1) DK0608235T4 (da)
ES (1) ES2081618T5 (da)
GR (1) GR3018646T3 (da)
HK (1) HK31697A (da)
WO (1) WO1993010261A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
PL181102B1 (pl) * 1993-01-29 2001-05-31 Dahlbaeck Bjoern Sposób oznaczania w próbce funkcjonalnej aktywności wybranego składnika koagulacji krwi
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
DE59410041D1 (de) * 1993-12-03 2002-03-21 Baxter Ag Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C
EP0696325B1 (en) 1994-02-14 1998-05-13 Rijksuniversiteit Leiden A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
AUPM731394A0 (en) * 1994-08-05 1994-09-01 Life Therapeutics Limited Improved activated protein c resistance test
ES2154703T5 (es) † 1994-11-10 2008-02-01 Dade Behring Marburg Gmbh Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
US5705395A (en) * 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US6867045B1 (en) 1994-11-14 2005-03-15 The Scripps Research Institute Method for diagnosis of thrombotic disorders
DE69520725T3 (de) † 1994-12-23 2005-11-17 Diagnostic Reagents Ltd., Thame Verfahren zur Diagnose von Blutgerinnungsstörungen
US5874256A (en) * 1995-06-06 1999-02-23 Rijks Universiteit Leiden Method for diagnosing an increased risk for thrombosis or a genetic defect causing thrombosis and kit for use with the same
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
AT403289B (de) * 1996-01-30 1997-12-29 Immuno Ag Verfahren zur herstellung eines standardisierten plasmapools für diagnostische zwecke
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
FR2764389B1 (fr) * 1997-06-06 1999-08-06 Stago Diagnostica Utilisation de venin de crotalus viridis helleri, procede et necessaire pour la determination de la reactivite de la proteine c activee
DE19724239A1 (de) * 1997-06-09 1998-12-10 Max Planck Gesellschaft Dysprothrombinämie
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US7696309B2 (en) * 2006-10-23 2010-04-13 The Brigham And Women's Hospital, Inc. Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
AU2012268078B2 (en) 2011-06-07 2017-06-01 Mesoblast International Sarl Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived Factor-1
RU2518247C2 (ru) * 2011-07-26 2014-06-10 Общество с ограниченной ответственностью "ГемаКор Лабс" (ООО "ГемаКор Лабс") Способ определения пространственно-временного распределения активности протеолитического фермента в гетерогенной системе, устройство для реализации указанного способа и способ диагностики нарушений системы гемостаза по изменению пространственно-временного распределения активности протеолитического фермента в гетерогенной системе
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
RU2752776C1 (ru) * 2020-12-16 2021-08-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ определения длительности тромбопрофилактики низкомолекулярным гепарином после абдоминального родоразрешения у носителей мутации Лейден, генотип F5 G1691A

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
WO1991001383A1 (en) * 1989-07-14 1991-02-07 Michigan State University Method for diagnosing blood clotting disorders
SE464135B (sv) † 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
US5169786A (en) * 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
ES2154703T5 (es) † 1994-11-10 2008-02-01 Dade Behring Marburg Gmbh Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
US5705395A (en) † 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders

Also Published As

Publication number Publication date
EP0608235B2 (en) 2005-05-04
WO1993010261A1 (en) 1993-05-27
JPH07501217A (ja) 1995-02-09
ATE132909T1 (de) 1996-01-15
EP0608235B1 (en) 1996-01-10
CA2119761C (en) 1997-12-16
JP2562000B2 (ja) 1996-12-11
AU666484B2 (en) 1996-02-15
EP0608235A1 (en) 1994-08-03
AU2198092A (en) 1993-06-15
ES2081618T5 (es) 2005-09-01
CA2119761A1 (en) 1993-05-27
GR3018646T3 (en) 1996-04-30
ES2081618T3 (es) 1996-03-16
DK0608235T3 (da) 1996-02-12
DE608235T1 (de) 1994-12-22
DE69207607D1 (de) 1996-02-22
DE69207607T3 (de) 2006-07-06
DE69207607T2 (de) 1996-06-20
HK31697A (en) 1997-03-21

Similar Documents

Publication Publication Date Title
DK0608235T4 (da) Fremgangsmåde til diagnose af blodkoagulationssygdomme
ATE240409T1 (de) Nicht-invasive pränatale diagnose
CA2282746A1 (en) Prediction of coronary artery disease
FR2824144B1 (fr) Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
ATE246357T1 (de) Gerät, das vakuum anwendet, zur auftrennung von körperflüssigkeiten
DK1323728T3 (da) Fremgangsmåde til diagnosticering af Alzheimers sygdom på basis af et genstransskriptionsmönster
NO982794L (no) Diagnostisering og behandling av AUR-1 og/eller AUR-2 relaterte lidelser
WO1997012992A3 (en) Diagnosis method for a disease caused by a frameshift mutation in a gene and reagents therefore
ES549777A0 (es) Procedimiento para la preparacion de un suero de control o calibrado
ES2151880T3 (es) Antagonistas de proteina de coagulacion de la sangre y sus utilizaciones.
DE59705683D1 (de) IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG
WO2003027309A3 (en) Diagnostic probe detection system
DK0947585T3 (da) Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter
DK0470969T3 (da) Fremgangsmåde til adskillelse og rensning af sialyltransferaser
HUP0200064A2 (en) A method for the high level expression of active lymphotoxin-betha receptor immunoglobulin chimeric proteins and their purification
DE3783966D1 (de) Reagens zur pruefung von periodentalen erkrankungen.
ES516496A0 (es) "procedimiento para la determinacion de hemoglobina glucosilada".
NO986218L (no) FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
HUP0303491A2 (hu) Magas vérnyomás kvantitatív diagnosztikai elemzése
WO2002086509A8 (en) Method and means for detecting gluten-induced diseases
DE69734890D1 (de) Rdgb-proteine
DK0587090T3 (da) Fremgangsmåde til bestemmelse af thromboseforårsagende lupus-antikoagulat-antistoffer.
WO2004016065A3 (es) SISTEMA Y PROCEDIMIENTO INMUNOCROMATOGRÁFICO PARA LA INDENTIFICACIÓN SIMULTÁNEA DE ANTICUERPOS FRENTE A AGA Y t-TG, Y SU USO EN EL DIAGNOSTICO DE ENFERMEDAD CELIACA
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
CA2332310A1 (en) Antibody against protein tyrosine phosphatase intracellular domains